Skip to main content
. 2021 Jan 22;36(8):2337–2348. doi: 10.1007/s00467-021-04928-w

Table 3.

Prevalence of KRT (pmarp) among 0–14-year-old children by country and year

Country Year
2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 Average
Albania* 4.7 4.9 8.5 7.0 7.2 11.1 9.5 7.5
Austria 40.4 41.8 46.3 40.3 43.1 40.1 36.9 38.4 40.4 41.4 40.9
Belarus* 19.0 20.5 21.2 22.5 20.8 21.7 23.3 24.8 24.3 22.0
Belgium* 57.2 53.7 49.3 46.1 36.6 48.6
Bosnia and Herzegovina* 14.8 14.8 18.1 20.9 20.2 20.2 18.2
Bulgaria* 17.3 10.7 11.7 10.2 12.5 13.1 8.0 18.0 10.0 12.4
Croatia* 29.4 32.5 29.9 30.3 40.6 42.7 36.8 40.6 51.0 37.1
Cyprus* 35.5 50.2 64.4 71.7 55.4
Czech Republic 23.8 21.7 22.2 22.5 26.8 22.6 22.9 26.4 28.5 27.5 24.6
Denmark 42.5 40.6 50.8 51.1 49.5 54.0 49.3 43.5 38.4 40.5 46.1
Estonia 10.0 15.1 10.0 4.9 9.8 9.7 9.6 9.6 19.0 18.8 11.7
Finland 92.4 80.6 80.9 82.2 84.4 85.4 85.1 89.3 97.0 80.4 85.8
France 30.1 32.9 35.6 36.0 35.8 35.3 36.9 37.8 39.0 39.0 35.9
Georgia* 7.8 18.3 19.1 20.9 16.5
Germany CERTAIN*1 20.5 17.6 21.6 16.8 19.2 20.2 22.7 19.8
Germany KfH*2 10.8 11.9 14.2 12.3
Greece 29.0 30.2 33.8 35.0 32.0 37.0 32.3 34.0 36.4 34.0 33.4
Hungary 32.9 28.7 33.0 29.3 30.4 33.4 37.8 35.8 38.6 40.7 34.0
Iceland 30.4 30.2 30.1 45.1 60.2 60.3 60.0 59.8 59.9 45.0 48.1
Ireland* 75.5 75.5
Italy*3 29.7 31.6 31.2 30.3 30.4 31.4 32.0 32.7 31.2 30.7 31.1
Latvia* 16.9 16.7 16.8
Lithuania 33.4 34.7 42.0 28.1 24.5 22.7 25.4 18.7 18.8 21.3 27.3
Malta* 63.7 64.6 65.0 64.9 64.2 31.6 31.0 55.0
Moldova* 6.9 1.7 4.3
Montenegro* 8.1 32.7 32.8 24.5
North Macedonia 18.3 16.0 19.1 19.4 22.4 14.2 17.2 11.5 14.4 14.5 16.8
the Netherlands 44.1 43.7 45.9 44.3 43.8 44.0 42.9 42.6 44.1 45.5 44.1
Norway 47.4 44.0 47.0 41.3 46.6 47.5 45.2 49.4 57.9 56.6 48.3
Poland* 34.4 34.8 37.7 40.6 40.6 40.8 41.0 40.1 38.7 38.7
Portugal 38.2 40.9 44.9 45.4 50.5 59.6 54.7 57.1 56.3 50.3 49.6
Romania 6.1 9.7 12.1 11.9 13.5 15.2 15.1 13.9 14.0 16.0 12.6
Russia 9.4 11.0 12.0 13.0 14.3 16.3 16.3 18.0 18.5 18.8 14.9
Serbia 24.5 35.6 35.9 31.5 29.7 30.0 29.2 28.3 30.3 29.5 30.4
Slovakia 27.8 26.0 27.5 26.4 25.2 21.6 26.5 21.7 20.5 19.1 24.2
Slovenia 17.8 31.9 31.5 38.1 34.2 37.1 30.0 36.3 22.9 32.5 31.3
Spain 39.7 40.4 42.2 39.2 41.4 39.9 40.3 41.0 41.0 43.3 40.6
Sweden 49.8 46.7 49.8 55.2 54.0 59.4 57.7 63.7 57.1 58.1 55.3
Switzerland*4 44.1 42.4 42.2 42.7 48.3 42.1 42.4 42.0 56.6 44.7
Turkey* 32.1 16.0 17.4 17.7 13.3 14.3 15.7 18.1
Ukraine* 8.3 7.8 10.0 11.6 13.2 12.5 13.4 11.0
UK 53.1 53.7 53.8 52.7 50.6 50.9 50.8 53.5 55.8 55.9 53.1
Total 29.4 30.6 32.4 32.0 32.5 33.4 33.3 34.4 35.3 35.6 32.9

KRT, kidney replacement therapy; pmarp, per million age-related population

*Not included in the total prevalence

1Data are based on transplantation patients only; therefore, the numbers are an underestimation of the true prevalence in Germany. The coverage ranged from 12 out of 20 centers in 2010 to 18 out of 20 centers in 2016. Each year around 120 patients under the age of 21 years are transplanted, of which 16% pre-emptively

2Dialysis patients only. In 2015, data from one dialysis center was not included, and the prevalence of dialysis patients is an underestimation of the true incidence

3(Pre-emptive) transplantation patients are not included; the prevalence is an underestimation of the true prevalence

4In 2013 and 2014, not all patients provided informed consent resulting in an underestimation of the true prevalence

5For 2010, data are based on patients aged 0–15 years. The prevalence is an underestimation of the true prevalence